Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl) amino]-and 4-(phenylamino) quinazolines as potent adenosine 5'- …

GW Rewcastle, WA Denny, AJ Bridges…

Index: Journal of Medicinal Chemistry, , vol. 38, # 18 p. 3482 - 3487

Full Text: HTML

Citation Number: 272

Abstract

... University of Auckland School of Medicine * Parke-Davis Pharmaceutical Research. @ Abstract published in Advance ACS Abstracts, August 1, 1996. ... Page 5. 3486 Journal of Medicinal Chemistry, 1995, Vol. 38, No. 18 Rewcastle et al. ...

Related Articles:

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging …

[Journal of Medicinal Chemistry, , vol. 48, # 16 p. 5337 - 5348]

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging …

[Journal of Medicinal Chemistry, , vol. 48, # 16 p. 5337 - 5348]

The combi-targeting concept: synthesis of stable nitrosoureas designed to inhibit the epidermal growth factor receptor (EGFR)

[Journal of Medicinal Chemistry, , vol. 49, # 12 p. 3544 - 3552]

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging …

[Journal of Medicinal Chemistry, , vol. 48, # 16 p. 5337 - 5348]

The combination of 4-anilinoquinazoline and cinnamic acid: A novel mode of binding to the epidermal growth factor receptor tyrosine kinase

[Bioorganic and Medicinal Chemistry, , vol. 19, # 16 p. 5012 - 5022]

More Articles...